BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37684712)

  • 41. Direct radiofrequency saturation corrected amide proton transfer tumor MRI at 3T.
    Wu Y; Chen Y; Zhao Y; Yang S; Zhao J; Zhou J; Chen Z; Sun PZ; Zheng H
    Magn Reson Med; 2019 Apr; 81(4):2710-2719. PubMed ID: 30390326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NOE-weighted imaging in tumors using low-duty-cycle 2π-CEST.
    Cui J; Sun C; Zu Z
    Magn Reson Med; 2023 Feb; 89(2):636-651. PubMed ID: 36198015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T.
    Xu X; Yadav NN; Zeng H; Jones CK; Zhou J; van Zijl PC; Xu J
    Magn Reson Med; 2016 Jan; 75(1):88-96. PubMed ID: 26445350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical Exchange Saturation Transfer MRI for Differentiating Radiation Necrosis From Tumor Progression in Brain Metastasis-Application in a Clinical Setting.
    Mehrabian H; Chan RW; Sahgal A; Chen H; Theriault A; Lam WW; Myrehaug S; Tseng CL; Husain Z; Detsky J; Soliman H; Stanisz GJ
    J Magn Reson Imaging; 2023 Jun; 57(6):1713-1725. PubMed ID: 36219521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correction of B1-inhomogeneities for relaxation-compensated CEST imaging at 7 T.
    Windschuh J; Zaiss M; Meissner JE; Paech D; Radbruch A; Ladd ME; Bachert P
    NMR Biomed; 2015 May; 28(5):529-37. PubMed ID: 25788155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advantages of chemical exchange-sensitive spin-lock (CESL) over chemical exchange saturation transfer (CEST) for hydroxyl- and amine-water proton exchange studies.
    Jin T; Kim SG
    NMR Biomed; 2014 Nov; 27(11):1313-24. PubMed ID: 25199631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimization of 7-T chemical exchange saturation transfer parameters for validation of glycosaminoglycan and amide proton transfer of fibroglandular breast tissue.
    Dula AN; Dewey BE; Arlinghaus LR; Williams JM; Klomp D; Yankeelov TE; Smith S
    Radiology; 2015 Apr; 275(1):255-61. PubMed ID: 25353249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T.
    Harris RJ; Cloughesy TF; Liau LM; Nghiemphu PL; Lai A; Pope WB; Ellingson BM
    NMR Biomed; 2016 Nov; 29(11):1563-1576. PubMed ID: 27717216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simplified assessment for chemical exchanged saturation transfer (CEST) imaging: local offset frequency and CEST effect.
    Chiba D; Kanazawa Y; Miyati T; Harada M; Miyoshi M; Hayashi H; Haga A
    Radiol Phys Technol; 2024 Mar; 17(1):93-102. PubMed ID: 37897684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the saturation pulse duration on chemical exchange saturation transfer in amide proton transfer MR imaging: a phantom study.
    Wada T; Togao O; Tokunaga C; Funatsu R; Kobayashi K; Nakamura Y
    Radiol Phys Technol; 2016 Jan; 9(1):15-21. PubMed ID: 26099607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variable delay multi-pulse train for fast chemical exchange saturation transfer and relayed-nuclear overhauser enhancement MRI.
    Xu J; Yadav NN; Bar-Shir A; Jones CK; Chan KW; Zhang J; Walczak P; McMahon MT; van Zijl PC
    Magn Reson Med; 2014 May; 71(5):1798-812. PubMed ID: 23813483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Dixon in magnetic resonance breast contrast-enhanced T1 weighted high-resolution imaging for mastectomy patients at 3T: A prospective study in single center.
    Fu Q; Liu J; Huang C; Zhou Q; Ou-Yang D; Sun P; Wang JZ; Lei ZQ; Yang F
    Magn Reson Imaging; 2024 Sep; 111():103-112. PubMed ID: 38685362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
    Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
    Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo visualization of mesoscopic anatomy of healthy and pathological lymph nodes using 7T MRI: a feasibility study.
    Freitag MT; Breithaupt M; Berger M; Umathum R; Nagel AM; Hassel J; Ladd ME; Schlemmer HP; Semmler W; Stieltjes B
    J Magn Reson Imaging; 2015 May; 41(5):1405-12. PubMed ID: 24976578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noninvasive Characterization of Metabolic Changes in Ischemic Stroke Using Z-spectrum-fitted Multiparametric Chemical Exchange Saturation Transfer-weighted Magnetic Resonance Imaging.
    Wang ZX; Wei XH; Cai KJ; Zhu WZ; Su CL
    Curr Med Sci; 2023 Oct; 43(5):970-978. PubMed ID: 37697160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3.0 T relaxation time measurements of human lymph nodes in adults with and without lymphatic insufficiency: Implications for magnetic resonance lymphatic imaging.
    Crescenzi R; Donahue PM; Braxton VG; Scott AO; Mahany HB; Lants SK; Donahue MJ
    NMR Biomed; 2018 Dec; 31(12):e4009. PubMed ID: 30311705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Creatine mapping of the brain at 3T by CEST MRI.
    Wang K; Huang J; Ju L; Xu S; Gullapalli RP; Liang Y; Rogers J; Li Y; van Zijl PCM; Weiss RG; Chan KWY; Xu J
    Magn Reson Med; 2024 Jan; 91(1):51-60. PubMed ID: 37814487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
    Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
    Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.